Tocilizumab Plus a Short Prednisone Taper for GCA
Clinical trial NCT03726749 · COMPLETED
Trial details
- NCT number
- NCT03726749
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-28
- Primary completion
- 2021-12-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.